| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Otitis Media | D010033 | 12 associated lipids |
| Whooping Cough | D014917 | 6 associated lipids |
| Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
All references with ERYTHROMYCIN ESTOLATE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Torre D et al. | Erythromycin estolate for treatment of pertussis. | 1986 Nov-Dec | Pediatr Infect Dis | pmid:3797311 |
| Ginsburg CM et al. | Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate. | 1982 Nov-Dec | Pediatr Infect Dis | pmid:6761656 |
| Ginsburg CM | A prospective study on the incidence of liver function abnormalities in children receiving erythromycin estolate, erythromycin ethylsuccinate or penicillin V for treatment of pneumonia. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3080735 |
| Hoppe JE | Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group. | 1992 | Pediatr. Infect. Dis. J. | pmid:1565532 |
| Krowchuk D and Seashore JH | Complete biliary obstruction due to erythromycin estolate administration in an infant. | 1979 | Pediatrics | pmid:514726 |
| Langley JM et al. | Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. | 2004 | Pediatrics | pmid:15231980 |
| Snellman LW et al. | Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. | 1993 | Pediatrics | pmid:8502522 |
| Halperin SA et al. | Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. | 1997 | Pediatrics | pmid:9200361 |
| Halperin SA et al. | A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection. | 1999 | Pediatrics | pmid:10506267 |
| Pari L and Murugan P | Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. | 2004 | Pharmacol. Res. | pmid:14998559 |